101 related articles for article (PubMed ID: 8323545)
1. A novel [99m]technetium-labeled nitroheterocycle capable of identification of hypoxia in heart.
Rumsey WL; Cyr JE; Raju N; Narra RK
Biochem Biophys Res Commun; 1993 Jun; 193(3):1239-46. PubMed ID: 8323545
[TBL] [Abstract][Full Text] [Related]
2. Effect of graded hypoxia on retention of technetium-99m-nitroheterocycle in perfused rat heart.
Rumsey WL; Patel B; Linder KE
J Nucl Med; 1995 Apr; 36(4):632-6. PubMed ID: 7699458
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis of technetium-99m-labeled nitroimidazole (BMS-181321) as a tracer of myocardial hypoxia.
Ng CK; Sinusas AJ; Zaret BL; Soufer R
Circulation; 1995 Sep; 92(5):1261-8. PubMed ID: 7648674
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of a putative hypoxic tissue marker, technetium-99m-nitroimidazole (BMS181321), in normoxic, hypoxic, ischemic and stunned myocardium.
Kusuoka H; Hashimoto K; Fukuchi K; Nishimura T
J Nucl Med; 1994 Aug; 35(8):1371-6. PubMed ID: 8046496
[TBL] [Abstract][Full Text] [Related]
5. Nitroimidazoles and hypoxia imaging: synthesis of three technetium-99m complexes bearing a nitroimidazole group: biological results.
Riché F; d'Hardemare AD; Sèpe S; Riou L; Fagret D; Vidal M
Bioorg Med Chem Lett; 2001 Jan; 11(1):71-4. PubMed ID: 11140737
[TBL] [Abstract][Full Text] [Related]
6. TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction.
Linder KE; Chan YW; Cyr JE; Malley MF; Nowotnik DP; Nunn AD
J Med Chem; 1994 Jan; 37(1):9-17. PubMed ID: 8289205
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of a putative hypoxic tracer, 99mTc-HL91, in normoxic, hypoxic, ischemic, and stunned myocardium.
Imahashi K; Morishita K; Kusuoka H; Yamamichi Y; Hasegawa S; Hashimoto K; Shirakami Y; Kato-Azuma M; Nishimura T
J Nucl Med; 2000 Jun; 41(6):1102-7. PubMed ID: 10855642
[TBL] [Abstract][Full Text] [Related]
8. Effects of no flow and reperfusion on technetium-99m-Q12 kinetics.
Okada RD; Nguyen KN; Lauinger M; Allton IL; Spreitzer K; Beju D; Johnson G
J Nucl Med; 1995 Nov; 36(11):2103-9. PubMed ID: 7472606
[TBL] [Abstract][Full Text] [Related]
9. Technetium 99m-Q12 kinetics in perfused rat myocardium: effects of hypoxia and low flow.
Okada RD; Nguyen KN; Lauinger M; Allton IL; Johnson G
Am Heart J; 1996 Jul; 132(1 Pt 1):108-15. PubMed ID: 8701850
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia.
Ballinger JR; Kee JW; Rauth AM
J Nucl Med; 1996 Jun; 37(6):1023-31. PubMed ID: 8683295
[TBL] [Abstract][Full Text] [Related]
11. The synthesis and in vitro evaluation of a 99mtechnetium-nitroimidazole complex based on a bis(amine-phenol) ligand: comparison to BMS-181321.
Ramalingam K; Raju N; Nanjappan P; Linder KE; Pirro J; Zeng W; Rumsey W; Nowotnik DP; Nunn AD
J Med Chem; 1994 Nov; 37(24):4155-63. PubMed ID: 7990115
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
Zhang Q; Huang H; Chu T
J Labelled Comp Radiopharm; 2016 Jan; 59(1):14-23. PubMed ID: 26690916
[TBL] [Abstract][Full Text] [Related]
13. Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes.
Huang H; Zhou H; Li Z; Wang X; Chu T
Bioorg Med Chem Lett; 2012 Jan; 22(1):172-7. PubMed ID: 22153341
[TBL] [Abstract][Full Text] [Related]
14. Direct detection of regional myocardial ischemia with technetium-99m nitroimidazole in rabbits.
Weinstein H; Reinhardt CP; Leppo JA
J Nucl Med; 1998 Apr; 39(4):598-607. PubMed ID: 9544663
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological results of the technetium-99m-labeled 4-nitroimidazole for imaging tumor hypoxia.
Chu T; Hu S; Wei B; Wang Y; Liu X; Wang X
Bioorg Med Chem Lett; 2004 Feb; 14(3):747-9. PubMed ID: 14741282
[TBL] [Abstract][Full Text] [Related]
16. Regional hypoxia correlates with the uptake of a radiolabeled targeted marker of angiogenesis in rat model of myocardial hypertrophy and ischemic injury.
Dobrucki LW; Meoli DF; Hu J; Sadeghi MM; Sinusas AJ
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():117-23. PubMed ID: 20083860
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of technetium-99m-teboroxime in reperfused nonviable myocardium.
Okada RD; Glover DK; Moffett JD; Beju D; Johnson G
J Nucl Med; 1997 Feb; 38(2):274-9. PubMed ID: 9025755
[TBL] [Abstract][Full Text] [Related]
18. Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: effect of lipophilicity.
Zhang X; Su ZF; Ballinger JR; Rauth AM; Pollak A; Thornback JR
Bioconjug Chem; 2000; 11(3):401-7. PubMed ID: 10821657
[TBL] [Abstract][Full Text] [Related]
19. Nitroimidazoles for imaging hypoxic myocardium.
Strauss HW; Nunn A; Linder K
J Nucl Cardiol; 1995; 2(5):437-45. PubMed ID: 9420823
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-labeled long chain fatty acid analogues metabolized by beta-oxidation in the heart.
Uehara T; Uemura T; Hirabayashi S; Adachi S; Odaka K; Akizawa H; Magata Y; Irie T; Arano Y
J Med Chem; 2007 Feb; 50(3):543-9. PubMed ID: 17266206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
